Amrize Ltd (AMRZ) concluded trading on Wednesday at a closing price of $51.47, with 4.14 million shares of worth about $212.83 million changed hands on the day. On July 23, 2025 the price saw a gain of about 2.37%. Currently the company’s common shares owned by public are about 552.74M shares, out of which, 494.11M shares are available for trading.
Stock saw a price change of 1.00% in past 5 days and over the past one month there was a price change of -1.00%. Over the period of past 52 weeks, stock dropped to lowest price of $48.01 but also hit the highest price of $56.29 during that period. The average intraday trading volume for Amrize Ltd shares is 3.86 million. The stock is currently trading 2.47% above its 20-day simple moving average (SMA20), while that difference is up 2.05% for SMA50 and it goes to 2.05% higher than SMA200.
Amrize Ltd (NYSE: AMRZ) currently have 552.74M outstanding shares and institutions hold larger chunk of about 0.47% of that.
The stock has a current market capitalization of $28.45B. It has Quick Ratio of 1.22 while making debt-to-equity ratio of 0.98. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AMRZ, volatility over the week remained 2.05% while standing at 2.35% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JP Morgan on July 15, 2025 offering an Overweight rating for the stock and assigned a target price of $57 to it. Coverage by Bernstein stated Amrize Ltd (AMRZ) stock as an Outperform in their note to investors on July 10, 2025, suggesting a price target of $62 for the stock. On July 01, 2025, Goldman Initiated their recommendations, while on June 30, 2025, Jefferies Initiated their ratings for the stock with a price target of $52.50. Stock get a Buy rating from Erste Group on June 30, 2025.
